You are using an older browser version. Please use a supported version for the best MSN experience.

China's CanSino Biologics will start clinical trials for inhaled Covid vaccine

Xuefeng Yu, co-founder and chief executive of CanSino Biologics, says a Covid-19 vaccine that can be inhaled could be more effective than those injected. CNBC's Arjun Kharpal reports.
image beaconimage beaconimage beacon